Interestingly, ABCC2 haplotype (−24T, 1249G, 3972T) was associated with imatinib resistance in chronic myeloid leukemia patients, suggesting a lower expression of MRP2 protein and reduced transport activity in haplotype carriers [47]. Here, ABCC2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.